+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Topical Hemostat Market by Product, Formulation, Application, End-Use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4989882
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Topical Hemostat Market grew from USD 2.12 billion in 2023 to USD 2.26 billion in 2024. It is expected to continue growing at a CAGR of 6.80%, reaching USD 3.36 billion by 2030.

The topical hemostat market encompasses products designed to control bleeding during surgical procedures by facilitating hemostasis at the site of application. These agents are crucial for minimizing blood loss, enhancing the visibility of the operative field, and reducing surgery-related complications. Topical hemostats are applied directly to the bleeding site and are used across various surgical disciplines including cardiovascular, neurological, and orthopedic surgeries. The end-use scope primarily covers hospitals, clinics, and ambulatory centers, where these products are in high demand due to the increasing volume of surgical procedures and trauma cases.

Key growth factors influencing the market include the rising incidence of chronic conditions necessitating surgeries, advancements in hemostatic technology, and increasing awareness about blood management strategies. Moreover, the expanding geriatric population, which is prone to surgeries, further propels demand. Potential opportunities lie in emerging markets with growing healthcare infrastructure and the development of novel hemostatic products offering superior efficacy and safety profiles. Firms can capitalize on these opportunities through strategic partnerships, investment in R&D for innovative product lines, and extensive market penetration strategies.

Nevertheless, market growth faces limitations such as the high cost of advanced hemostatic agents and stringent regulatory pathways that may impede swift product approvals. Competition from alternative coagulation technologies and the potential for adverse reactions also pose challenges. Addressing these challenges necessitates investments in clinical trials to demonstrate safety and cost-effectiveness, alongside strategies to streamline manufacturing processes for cost reduction.

Innovation avenues include the development of multifunctional hemostats that incorporate antimicrobial properties or deliver targeted drug therapies, thereby enhancing product value. Research focusing on biocompatible, sustainable materials and bioengineered products can also drive growth. The nature of the market remains competitive and innovation-driven, with substantial potential for companies that leverage technological advancements and address unmet clinical needs.

Understanding Market Dynamics in the Topical Hemostat Market

The Topical Hemostat Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising numbers of surgeries due to an aging population and prevalence of chronic diseases
    • Favorable product approval by medical regulators
  • Market Restraints
    • High costs associated with topical hemostat products
  • Market Opportunities
    • Ongoing R&D for the introduction of novel topical hemostat
    • Integration of nanotechnology to create more efficient topical hemostats
  • Market Challenges
    • Operational limitations and risk of infection associated with the use of topical hemostats

Exploring Porter’s Five Forces for the Topical Hemostat Market

Porter’s Five Forces framework further strengthens the insights of the Topical Hemostat Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Topical Hemostat Market

External macro-environmental factors deeply influence the performance of the Topical Hemostat Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Topical Hemostat Market

The Topical Hemostat Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Topical Hemostat Market

The Topical Hemostat Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Topical Hemostat Market

The Topical Hemostat Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Topical Hemostat Market, highlighting leading vendors and their innovative profiles. These include Aegis Lifesciences Private Limited, Axio Biosolutions Pvt Ltd, B.Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Betatech Medical, BioCer Entwicklungs-GmbH, Bristol-Myers Squibb Company, Dilon Technologies Inc, GELITA MEDICAL GmbH, Hemostasis, LLC, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Marine Polymer Technologies, Inc., Medline Industries, LP, Medtrade Products Ltd, Medtronic PLC, Meril Life Sciences Pvt. Ltd, Pfizer Inc., Southmedic Inc., Stryker Corporation, SYMATESE SAS, Takeda Pharmaceutical Company Limited, Teleflex Incorporated, and Zeria Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Topical Hemostat Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Collagen-Based Topical Hemostats
    • Combination Topical Hemostats
    • Gelatin-Based Topical Hemostats
    • Oxidized Regenerated Cellulose-based Topical Hemostats
    • Thrombin-Based Topical Hemostats
  • Formulation
    • Matrix & Gel Hemostats
    • Powder Hemostats
    • Sheet & Pad Hemostats
    • Sponge Hemostats
  • Application
    • Cardiovascular Surgery
    • General Surgery
    • Liver & Spleen Lacerations
    • Orthopedic Surgery
    • Reconstructive Surgery
  • End-Use
    • Hospitals
    • Nursing Homes
    • Surgical Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising numbers of surgeries due to an aging population and prevalence of chronic diseases
5.1.1.2. Favorable product approval by medical regulators
5.1.2. Restraints
5.1.2.1. High costs associated with topical hemostat products
5.1.3. Opportunities
5.1.3.1. Ongoing R&D for the introduction of novel topical hemostat
5.1.3.2. Integration of nanotechnology to create more efficient topical hemostats
5.1.4. Challenges
5.1.4.1. Operational limitations and risk of infection associated with the use of topical hemostats
5.2. Market Segmentation Analysis
5.2.1. Product: Burgeoning adoption of combination topical hemostats owing to the additional benefits such as infection reduction
5.2.2. Formulation: Proliferating utilization of matrix and gel hemostats owing to their ability to conform to irregular wound surfaces
5.2.3. Application: Significant usage of topical hemostats in cardiovascular surgery
5.2.4. End-Use: Evolving utilization of topical hemostats in hospitals
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Topical Hemostat Market, by Product
6.1. Introduction
6.2. Collagen-Based Topical Hemostats
6.3. Combination Topical Hemostats
6.4. Gelatin-Based Topical Hemostats
6.5. Oxidized Regenerated Cellulose-based Topical Hemostats
6.6. Thrombin-Based Topical Hemostats
7. Topical Hemostat Market, by Formulation
7.1. Introduction
7.2. Matrix & Gel Hemostats
7.3. Powder Hemostats
7.4. Sheet & Pad Hemostats
7.5. Sponge Hemostats
8. Topical Hemostat Market, by Application
8.1. Introduction
8.2. Cardiovascular Surgery
8.3. General Surgery
8.4. Liver & Spleen Lacerations
8.5. Orthopedic Surgery
8.6. Reconstructive Surgery
9. Topical Hemostat Market, by End-Use
9.1. Introduction
9.2. Hospitals
9.3. Nursing Homes
9.4. Surgical Centers
10. Americas Topical Hemostat Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Topical Hemostat Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Topical Hemostat Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Ethicon Introduces ETHIZIA Hemostatic Sealing Patch, Clinically Proven to Stop Disruptive Bleeding
13.3.2. Medcura Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
13.3.3. Hemostasis Closes Acquisition of Fiagon Medical Technologies
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. TOPICAL HEMOSTAT MARKET RESEARCH PROCESS
FIGURE 2. TOPICAL HEMOSTAT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. TOPICAL HEMOSTAT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. TOPICAL HEMOSTAT MARKET DYNAMICS
TABLE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY LIVER & SPLEEN LACERATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 41. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 47. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 63. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 65. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 67. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 69. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 75. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 77. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 101. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 114. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 116. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 118. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 120. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 122. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 126. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 130. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 136. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 138. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 148. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 150. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 152. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 154. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 156. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 158. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 172. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 174. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 184. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 186. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 196. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 197. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Topical Hemostat Market, which are profiled in this report, include:
  • Aegis Lifesciences Private Limited
  • Axio Biosolutions Pvt Ltd
  • B.Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Betatech Medical
  • BioCer Entwicklungs-GmbH
  • Bristol-Myers Squibb Company
  • Dilon Technologies Inc
  • GELITA MEDICAL GmbH
  • Hemostasis, LLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Marine Polymer Technologies, Inc.
  • Medline Industries, LP
  • Medtrade Products Ltd
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd
  • Pfizer Inc.
  • Southmedic Inc.
  • Stryker Corporation
  • SYMATESE SAS
  • Takeda Pharmaceutical Company Limited
  • Teleflex Incorporated
  • Zeria Pharmaceutical Co., Ltd.

Methodology

Loading
LOADING...

Table Information